Skip to main content
Top
Published in: Journal of Translational Medicine 1/2012

Open Access 01-12-2012 | Research

Plasma nuclear and mitochondrial DNA levels as predictors of outcome in severe sepsis patients in the emergency room

Authors: Chia-Te Kung, Sheng-Yuan Hsiao, Tsung-Cheng Tsai, Chih-Min Su, Wen-Neng Chang, Chi-Ren Huang, Hung-Chen Wang, Wei-Che Lin, Hsueh-Wen Chang, Yu-Jun Lin, Ben-Chung Cheng, Ben Yu-Jih Su, Nai-Wen Tsai, Cheng-Hsien Lu

Published in: Journal of Translational Medicine | Issue 1/2012

Login to get access

Abstract

Background and aim

The sensitivity and specificity of biomarkers and scoring systems used for predicting fatality of severe sepsis patients remain unsatisfactory. This study aimed to determine the prognostic value of circulating plasma DNA levels in severe septic patients presenting at the Emergency Department (ED).

Methods

Sixty-seven consecutive patients with severe sepsis and 33 controls were evaluated. Plasma DNA levels were estimated by real-time quantitative polymerase chain reaction assay using primers for the human β-hemoglobin and ND2 gene. The patients’ clinical and laboratory data on admission were analyzed.

Results

The median plasma nuclear and mitochondria DNA levels for severe septic patients on admission were significantly higher than those of the controls. The mean plasma nuclear DNA level on admission correlated with lactate concentration (γ = 0.36, p = 0.003) and plasma mitochondrial DNA on admission (γ = 0.708, p < 0.001). Significant prognostic factors for fatality included mechanical ventilation within the first 24 hours (p = 0.013), mean sequential organ failure assessment (SOFA) score on admission (p = 0.04), serum lactate (p < 0.001), and both plasma nuclear and mitochondrial DNA on admission (p < 0.001). Plasma mitochondrial DNA was an independent predictor of fatality by stepwise logistic regression such that an increase by one ng/mL in level would increase fatality rate by 0.7%.

Conclusion

Plasma DNA has potential use for predicting outcome in septic patients arriving at the emergency room. Plasma mitochondrial DNA level on admission is a more powerful predictor than lactate concentration or SOFA scores on admission.
Appendix
Available only for authorised users
Literature
1.
go back to reference Martin GS, Mannino DM, Eaton S, Moss M: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003, 348: 1546-1554. 10.1056/NEJMoa022139.CrossRefPubMed Martin GS, Mannino DM, Eaton S, Moss M: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003, 348: 1546-1554. 10.1056/NEJMoa022139.CrossRefPubMed
2.
go back to reference Leon SA, Shapiro B, Sklaroff DM, Yaros MJ: Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res. 1977, 37: 646-650.PubMed Leon SA, Shapiro B, Sklaroff DM, Yaros MJ: Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res. 1977, 37: 646-650.PubMed
3.
go back to reference Jiang N, Pisetsky DS: The effect of inflammation on the generation of plasma DNA from dead and dying cell in the peritoneum. J Leukoc Biol. 2005, 77: 1-7. Jiang N, Pisetsky DS: The effect of inflammation on the generation of plasma DNA from dead and dying cell in the peritoneum. J Leukoc Biol. 2005, 77: 1-7.
4.
go back to reference Jahr S, Hentze H, English S, Hardt D, Fackelmayer FO, Hesch RD, Knippers R: DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res. 2001, 61: 1659-1665.PubMed Jahr S, Hentze H, English S, Hardt D, Fackelmayer FO, Hesch RD, Knippers R: DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res. 2001, 61: 1659-1665.PubMed
5.
go back to reference Tsumita T, Iwanagam M: Fate of injected deoxyribonucleic acid in mice. Nature. 1963, 198: 1088-1089. 10.1038/1981088a0.CrossRefPubMed Tsumita T, Iwanagam M: Fate of injected deoxyribonucleic acid in mice. Nature. 1963, 198: 1088-1089. 10.1038/1981088a0.CrossRefPubMed
6.
go back to reference Lo YM, Rainer TH, Chan LY, Hjelm NM, Cocks RA: Plasma DNA as a prognostic marker in trauma patients. Clin Chem. 2000, 46: 319-323.PubMed Lo YM, Rainer TH, Chan LY, Hjelm NM, Cocks RA: Plasma DNA as a prognostic marker in trauma patients. Clin Chem. 2000, 46: 319-323.PubMed
7.
go back to reference Chang CP, Chia RH, Wu TL, Tsao KC, Sun CF, Wu JT: Elevated cell-free serum DNA detected in patients with myocardial infarction. Clin Chim Acta. 2003, 327: 95-101. 10.1016/S0009-8981(02)00337-6.CrossRefPubMed Chang CP, Chia RH, Wu TL, Tsao KC, Sun CF, Wu JT: Elevated cell-free serum DNA detected in patients with myocardial infarction. Clin Chim Acta. 2003, 327: 95-101. 10.1016/S0009-8981(02)00337-6.CrossRefPubMed
8.
go back to reference Rainer TH, Wong LK, Lam W, Yuen E, Lam NY, Metreweli C, Lo YM: Prognostic use of circulating plasma nucleic acid concentrations in patients with acute stroke. Clin Chem. 2003, 49: 562-569. 10.1373/49.4.562.CrossRefPubMed Rainer TH, Wong LK, Lam W, Yuen E, Lam NY, Metreweli C, Lo YM: Prognostic use of circulating plasma nucleic acid concentrations in patients with acute stroke. Clin Chem. 2003, 49: 562-569. 10.1373/49.4.562.CrossRefPubMed
9.
go back to reference Saukkonen K, Lakkisto P, Pettila V, Varpula M, Karlsson S, Ruokonen E, Pulkki K: Cell-free plasma DNA as a predictor of outcome in severe sepsis and septic shock. Clin Chem. 2008, 54: 1000-1007. 10.1373/clinchem.2007.101030.CrossRefPubMed Saukkonen K, Lakkisto P, Pettila V, Varpula M, Karlsson S, Ruokonen E, Pulkki K: Cell-free plasma DNA as a predictor of outcome in severe sepsis and septic shock. Clin Chem. 2008, 54: 1000-1007. 10.1373/clinchem.2007.101030.CrossRefPubMed
10.
go back to reference Huang CH, Tsai MS, Hsu CY, Chen HW, Wang TD, Chang WT, Ma MH, Chien KL, Chen SC, Chen WJ: Circulating cell-free DNA levels correlate with post-resuscitation survival rates in out-of-hospital cardiac arrest patients. Resuscitation. 2012, 83: 213-218. 10.1016/j.resuscitation.2011.07.039.CrossRefPubMed Huang CH, Tsai MS, Hsu CY, Chen HW, Wang TD, Chang WT, Ma MH, Chien KL, Chen SC, Chen WJ: Circulating cell-free DNA levels correlate with post-resuscitation survival rates in out-of-hospital cardiac arrest patients. Resuscitation. 2012, 83: 213-218. 10.1016/j.resuscitation.2011.07.039.CrossRefPubMed
11.
go back to reference Okkonen M, Lakkisto P, Korhonen AM, Parviai-nen I, Reinikainen M, Varpula T, Pettilä V: Plasma cell-free DNA in patients needing mechanical ventilation. Crit Care. 2011, 15: R196-10.1186/cc10357.CrossRefPubMedPubMedCentral Okkonen M, Lakkisto P, Korhonen AM, Parviai-nen I, Reinikainen M, Varpula T, Pettilä V: Plasma cell-free DNA in patients needing mechanical ventilation. Crit Care. 2011, 15: R196-10.1186/cc10357.CrossRefPubMedPubMedCentral
12.
go back to reference Hotchkiss RS, Nicholson DW: Apoptosis and caspases regulate death and inflammation in the sepsis. Nat Rev Immunol. 2006, 6: 813-822. 10.1038/nri1943.CrossRefPubMed Hotchkiss RS, Nicholson DW: Apoptosis and caspases regulate death and inflammation in the sepsis. Nat Rev Immunol. 2006, 6: 813-822. 10.1038/nri1943.CrossRefPubMed
13.
go back to reference Martins GA, Kawamura MT, Carvalho Mda G: Detection of DNA in the plasma of septic patients. Ann NY Acad Sci. 2000, 906: 134-140.CrossRefPubMed Martins GA, Kawamura MT, Carvalho Mda G: Detection of DNA in the plasma of septic patients. Ann NY Acad Sci. 2000, 906: 134-140.CrossRefPubMed
14.
go back to reference Zeerleder S, Zwart B, Wuillemin WA, Aarden LA, Groeneveld AB, Caliezi C, van Nieuwenhuijze A, van Mierlo GJ, Eerenberg AJ, Lammle B, Hack CE: Elevated nucleosome levels in systemic inflammation and sepsis. Crit Care Med. 2003, 31: 1947-1951. 10.1097/01.CCM.0000074719.40109.95.CrossRefPubMed Zeerleder S, Zwart B, Wuillemin WA, Aarden LA, Groeneveld AB, Caliezi C, van Nieuwenhuijze A, van Mierlo GJ, Eerenberg AJ, Lammle B, Hack CE: Elevated nucleosome levels in systemic inflammation and sepsis. Crit Care Med. 2003, 31: 1947-1951. 10.1097/01.CCM.0000074719.40109.95.CrossRefPubMed
15.
go back to reference Rhodes A, Wort SJ, Thomas H, Collinson P, Bennett ED: Plasma DNA concentration as predictor of mortality and sepsis in critically ill patients. Crit Care. 2006, 10: R60-10.1186/cc4894.CrossRefPubMedPubMedCentral Rhodes A, Wort SJ, Thomas H, Collinson P, Bennett ED: Plasma DNA concentration as predictor of mortality and sepsis in critically ill patients. Crit Care. 2006, 10: R60-10.1186/cc4894.CrossRefPubMedPubMedCentral
16.
go back to reference American College of Chest Physicians/ Society of Critical Care Medicine Consensus Committee: Definition for sepsis and organ failures and guidelines for the use of innovative therapies in sepsis. Chest. 1992, 101: 1658-1662. American College of Chest Physicians/ Society of Critical Care Medicine Consensus Committee: Definition for sepsis and organ failures and guidelines for the use of innovative therapies in sepsis. Chest. 1992, 101: 1658-1662.
17.
go back to reference Lo YM, Tein MS, Lau TK, Haines CJ, Leung TN, Poon PM, Wainscoat JS, Johnson PJ, Chang AM, Hjelm NM: Quantitative analysis of fetal DNA in maternal plasma and serum: implications for non-invasive pre-natal diagnosis. Am J Hum Genet. 1998, 62: 768-775. 10.1086/301800.CrossRefPubMedPubMedCentral Lo YM, Tein MS, Lau TK, Haines CJ, Leung TN, Poon PM, Wainscoat JS, Johnson PJ, Chang AM, Hjelm NM: Quantitative analysis of fetal DNA in maternal plasma and serum: implications for non-invasive pre-natal diagnosis. Am J Hum Genet. 1998, 62: 768-775. 10.1086/301800.CrossRefPubMedPubMedCentral
18.
go back to reference Chiu RW, Chan LY, Lam NY, Tsui NB, Ng EK, Rainer TH, Lo YM: Quantitative analysis of circulating mitochondrial DNA in plasma. Clin Chem. 2003, 49: 719-726. 10.1373/49.5.719.CrossRefPubMed Chiu RW, Chan LY, Lam NY, Tsui NB, Ng EK, Rainer TH, Lo YM: Quantitative analysis of circulating mitochondrial DNA in plasma. Clin Chem. 2003, 49: 719-726. 10.1373/49.5.719.CrossRefPubMed
19.
go back to reference Brunelle JK, Chandel NS: Oxygen deprivation induced cell death: an update. Apoptosis. 2002, 7: 475-482. 10.1023/A:1020668923852.CrossRefPubMed Brunelle JK, Chandel NS: Oxygen deprivation induced cell death: an update. Apoptosis. 2002, 7: 475-482. 10.1023/A:1020668923852.CrossRefPubMed
20.
go back to reference Huttunen R, Kuparinen T, Jylhava J: Fatal outcome in bacteremia is characterized by high plasma cell free DNA concentration and apoptotic DNA fragmentation: A prospective cohort study. PLoS One. 2011, 6: e21700-10.1371/journal.pone.0021700.CrossRefPubMedPubMedCentral Huttunen R, Kuparinen T, Jylhava J: Fatal outcome in bacteremia is characterized by high plasma cell free DNA concentration and apoptotic DNA fragmentation: A prospective cohort study. PLoS One. 2011, 6: e21700-10.1371/journal.pone.0021700.CrossRefPubMedPubMedCentral
21.
go back to reference Labbeand K, Saleh M: Cell death in the host response to infection. Cell Death Differ. 2008, 15: 1339-1349. 10.1038/cdd.2008.91.CrossRef Labbeand K, Saleh M: Cell death in the host response to infection. Cell Death Differ. 2008, 15: 1339-1349. 10.1038/cdd.2008.91.CrossRef
Metadata
Title
Plasma nuclear and mitochondrial DNA levels as predictors of outcome in severe sepsis patients in the emergency room
Authors
Chia-Te Kung
Sheng-Yuan Hsiao
Tsung-Cheng Tsai
Chih-Min Su
Wen-Neng Chang
Chi-Ren Huang
Hung-Chen Wang
Wei-Che Lin
Hsueh-Wen Chang
Yu-Jun Lin
Ben-Chung Cheng
Ben Yu-Jih Su
Nai-Wen Tsai
Cheng-Hsien Lu
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Journal of Translational Medicine / Issue 1/2012
Electronic ISSN: 1479-5876
DOI
https://doi.org/10.1186/1479-5876-10-130

Other articles of this Issue 1/2012

Journal of Translational Medicine 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine